Provectus Biopharmaceuticals (PVCT) Current Deferred Revenue (2021 - 2025)
Provectus Biopharmaceuticals (PVCT) recorded Current Deferred Revenue of $57,480 in Q1 2025, down 92.0% from $715,176 a year earlier and down 82.9% from the prior quarter.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Current Deferred Revenue (2021 - 2025) Analysis & Trends
At the end of FY2024, Provectus Biopharmaceuticals reported Current Deferred Revenue of $336,108, down 64.7% from FY2023.
- Annual Current Deferred Revenue has declined for three straight years, with a three-year compound annual growth rate of -48.8% (FY2021 to FY2024).
- Across earlier years, Current Deferred Revenue came in at $953,248 in FY2023 (-36.9%), $1.51 million in FY2022 (-39.6%) and $2.5 million in FY2021.
- The Q1 2025 figure is the lowest quarterly Current Deferred Revenue in data going back to Q4 2021.
- On a year-over-year basis, Current Deferred Revenue has declined for ten consecutive quarters, with an average decline of 55.6% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 35.9% in Q3 2023 to 92.0% in Q1 2025.
- Per Business Quant, the preceding three quarters came in at $336,108 (Q4 2024), $350,440 (Q3 2024) and $460,185 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 57,480.00 |
| Dec 31, 2024 | 336,108.00 |
| Sep 30, 2024 | 350,440.00 |
| Jun 30, 2024 | 460,185.00 |
| Mar 31, 2024 | 715,176.00 |
| Dec 31, 2023 | 953,248.00 |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 2.50 Mn |
API Access
Provectus Biopharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();